Maayan Eshed, G., & Alcalay, R. N. (2024). GBA1-and LRRK2-directed Treatments: The Way Forward. Parkinsonism & Related Disorders, 122, 106039. https://doi.org/10.1016/j.parkreldis.2024.106039

Fernandez, H. H., Macklin, E. A., Hauser, R. A., Chou, K. L., Cakmak, Y. O., Ozsoy, B., & Fahn, S. (2024). Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results. Parkinsonism & Related Disorders, 121, 105959. https://doi.org/10.1016/j.parkreldis.2023.105959

Kipnis, D., Pacheco, A., Delfing, D., Toomer-Mensah, N., Macpherson, C. E., Rieger, J., Parker, A., Coley, R. B., Coley, D., Shah, H., & Quinn, L. (2024). Community-based participatory research approach to address healthcare disparities confronting members of the Black Diaspora with Parkinson’s disease. Parkinsonism & Related Disorders, 119, 105936. https://doi.org/10.1016/j.parkreldis.2023.105936

York, M. K., & Alcalay, R. N. (2023). Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism & Related Disorders, 111, 105403. https://doi.org/10.1016/j.parkreldis.2023.105403

Shani, S., Goldstein, O., Gana-Weisz, M., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., & Orr-Urtreger, A. (2023). Variants in PSMB9 and FGR differentially affect Parkinson’s disease risk in GBA and LRRK2 mutation carriers. Parkinsonism & Related Disorders, 111, 105398. https://doi.org/10.1016/j.parkreldis.2023.105398

Lai, R.-Y., Desai, N. A., Amlang, C. J., Lin, C.-Y. R., Chen, T. X., Minyetty, M. J., Amokrane, N., & Kuo, S.-H. (2023). Gambling associated risk-taking decision in cerebellar ataxia. Parkinsonism & Related Disorders, 107, 105252. https://doi.org/10.1016/j.parkreldis.2022.105252

Bukhari, S. A., Nudelman, K. N. H., Rumbaugh, M., Richeson, P., Fox, E. J., Montine, K. S., Aldecoa, I., Garrido, A., Franz, J., Stadelmann, C., Vonsattel, J. P. G., Poston, K. L., Foroud, T. M., & Montine, T. J. (2022). Parkinson’s Progression Markers Initiative brain autopsy program. Parkinsonism & Related Disorders, 101, 62–65. https://doi.org/10.1016/j.parkreldis.2022.06.017

Quinn, L., Playle, R., Drew, C. J. G., Taiyari, K., Williams-Thomas, R., Muratori, L. M., Hamana, K., Griffin, B. A., Kelson, M., Schubert, R., Friel, C., Morgan-Jones, P., Rosser, A., Busse, M., Montojo, T., Ruiz Idiago, J. M., Hershberg, J., Marder, K., Bordelon, Y., … Landwehrmeyer, B. (2022). Physical activity and exercise outcomes in Huntington’s disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington’s disease. Parkinsonism & Related Disorders, 101, 75–89. https://doi.org/10.1016/j.parkreldis.2022.06.013

Miller, J. R., Chapman, S., Hernandez, D. I., Radler, K., Delgado, N., Huey, E. D., Louis, E. D., & Cosentino, S. (2022). Depressive symptoms predict memory decline in Essential Tremor. Parkinsonism & Related Disorders, 98, 16–20. https://doi.org/10.1016/j.parkreldis.2022.03.013

Iannuzzelli, K., Shi, R., Carter, R., Huynh, R., Morgan, O., Kuo, S.-H., Bang, J., Mills, K. A., Baranano, K., Zee, D. S., Moukheiber, E., Roda, R., Butala, A., Marvel, C., Joyce, M., Li, X., Wang, J., & Rosenthal, L. S. (2022). The association between educational attainment and SCA 3 age of onset and disease course. Parkinsonism & Related Disorders, 98, 99–102. https://doi.org/10.1016/j.parkreldis.2022.02.025